Point72 Asset Management
LCTX icon

Point72 Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Point72 Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,786
Closed -$20.7K – 1914
2023
Q1 		$20.7K Buy
+13,786
New +$20.7K ﹤0.01% 1438